No Data
J.P. Morgan Maintains BioNTech(BNTX.US) With Hold Rating, Announces Target Price $122
J.P. Morgan Reaffirms Their Hold Rating on BioNTech SE (BNTX)
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Morgan Stanley Sticks to Its Buy Rating for BioNTech SE (BNTX)
FDA Lifts Hold on BioNTech's Key Cancer Trial
BioNTech Says Partial Clinical Hold on BNT316 Study Lifted
TheGerries : So when is our turn?
Den the Dragon : ,
Jaguar8 OP TheGerries : ???
103622690 DK : I really admire you, and I'm curious how you pick your watchlist from so many options, and even repeatedly select those with upward trends, leading to explosive gains the next day... I really want to learn from you, Master. 🫡
Jaguar8 OP 103622690 DK : If I have time and teach during weekends. It also takes experience to get the feel which stock are quite positive . There are misses too but often times they go up in the next days
View more comments...